Texas Woman's University   Report issue

Academic/Hospital Phase 2
Founded: Denton TX United States (1901)

Organization Overview

First Clinical Trial
2011
NCT01385098
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Pingale, Vidya, OTR | Texas Woman's University | Texas Woman's University Kinesiology Department | Texas Woman's University & TIRR Memorial Hermann

Active Ingredients

Drugs in Phase 2 Trials (2)

pumpkin seeds (3 trials)

tocotrienol (1 trial)

Drugs in Other Trials (7)

caffeine (1 trial)

calcium (1 trial)

leucine (1 trial)

l-isoleucine (1 trial)

potato (1 trial)

vitamin d3 (2 trials)

vitis vinifera (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Osteoporosis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 10
  • # of Trial APIs: 9